Caminomed

The trials here

What the 5 trials at this site are about, from their registry records.

Conditions

• Macular degeneration3 trials
• Diabetic eye disease2 trials

Phase

• Phase 22 trials
• Phase 32 trials

Status

• Completed4 trials
• Terminated1 trial

Lead sponsor

• Hoffmann-La Roche3 trials
• Gyroscope Therapeutics Limited1 trial
• Rophibio Inc.1 trial

Closed trials

• Completed

  A Clinical Trial to compare Efficacy, Safety, Tolerability of RBS-001 to Eylea® in Subjects with Neovascular Age-Related Macular Degeneration

  2023-509206-29-00· Phase 3· Rophibio Inc.· Source

• Completed

  A Study to Investigate Vamikibart (RO7200220) in Diabetic Macular Edema

  NCT05151731· Phase 2· Hoffmann-La Roche· Source

• Completed

  A Study to Investigate Vamikibart (RO7200220) in Combination With Ranibizumab in Diabetic Macular Edema

  NCT05151744· Phase 2· Hoffmann-La Roche· Source

• Completed

  A Study to Evaluate the Long-Term Safety and Tolerability of Faricimab in Participants With Neovascular Age-Related Macular Degeneration

  NCT04777201· Phase 3· Hoffmann-La Roche· Source

• Terminated

  GTSCOPE - To Evaluate the Natural Progression of Dry Age-related Macular Degeneration (AMD)

  NCT03894020· Gyroscope Therapeutics Limited· Source